Entering text into the input field will update the search result below

Pfizer to supply 10M courses of COVID drug Paxlovid to developing nations in 2022- Reuters

Mar. 03, 2022 5:56 AM ETPfizer Inc. (PFE)MRKBy: Ravikash, SA News Editor1 Comment

Pfizer Makes $1.95 Billion Deal With U.S. For Future COVID-19 Vaccine

Jeenah Moon/Getty Images News

  • Pfizer (NYSE:PFE) is expected to provide about 10M courses its COVID-19 therapy Paxlovid to low and middle-income nations in 2022, Reuters reported citing Harley Feldbaum, head of strategy for policy at Global Fund, a non-government organization.
  • The company

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.